Cellebrite DI (CLBT) EBT (2020 - 2025)

Cellebrite DI (CLBT) has reported EBT for 6 consecutive years, with $26.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, EBT rose 32.03% year-over-year to $26.3 million; the TTM figure through Dec 2025 stood at $90.7 million (up 132.86% YoY), while the FY2025 annual figure was $90.7 million, up 132.86% from the prior year.
• EBT came in at $26.3 million for Q4 2025 at Cellebrite DI, up from $24.3 million in the prior quarter.
• The five-year high for EBT was $54.5 million in Q1 2022, with the low at -$204.5 million in Q3 2024.
• Average EBT over 5 years is -$2.9 million, with a median of $11.9 million recorded in 2021.
• Across the five-year window, EBT jumped 1045.68% in 2022 and slumped 3086.38% in 2024, its largest moves.
• Year by year, EBT stood at $54.1 million in 2021, then tumbled by 83.18% to $9.1 million in 2022, then tumbled by 235.63% to -$12.3 million in 2023, then soared by 261.17% to $19.9 million in 2024, then soared by 32.03% to $26.3 million in 2025.
• According to Business Quant data, EBT over the past three periods registered $26.3 million, $24.3 million, and $20.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.